Proactive Investors - Run By Investors For Investors

Breakfast News - AIM Breakfast : Armadale Capital PLC, DP Poland Plc, Hotel Chocolat Group, Horizon Discovery Group PLC, PCF Group Plc, ReNeuron Group Plc, Tiziana Life Sciences, Tlou Energy Ltd, The People's Operator, Venture Life Group

Breakfast News - AIM Breakfast :  Armadale Capital PLC, DP Poland Plc, Hotel Chocolat Group, Horizon Discovery Group PLC, PCF Group Plc, ReNeuron Group Plc, Tiziana Life Sciences, Tlou Energy Ltd, The People's Operator, Venture Life Group

What’s cooking in the IPO kitchen?


Xpediator Plc—Sch 1 from the holding Company for an integrated freight management business operating in the supply chain logistics and fulfilment sector across the UK and Europe with a strong presence in Central and Eastern Europe. Offer details TBC, expected Admission early August 2017.

GetBusy PLC—Sch1 from the holding Company of its subsidiary undertakings, which operates as a document management software business with over 110 full time employees, headquartered in Cambridge, UK and operating across the UK, USA, Australia and New Zealand.  Capital to be raised via a rights issues of £3m at 28.3p with anticipated market cap of £13.7m.

Work Group Plc—Sch1 from the Company that proposes to acquire the entire issued share capital of Gordon Dadds Group Limited (GDG). GDG is an acquisitive law firm and a group of other complimentary businesses, including Prolegal, an acquisition vehicle model focused on smaller law firm. Capital to be raised is £20m with anticipated market cap of £40m.

Quiz—Sch 1 from the omni-channel and international own brand in the women's value fast fashion sector.  Offer TBA. Expected late July.  Last year Quiz posted sales of £87.4m while pre-tax profits grew by 17pc to £5.7m .

Arena Events Group -provider of temporary physical structures, seating, ice rinks, furniture and interiors. Raising £60m. Mkt cap £63m. Expected on the Chef’s birthday, 25th July.

Altus Strategies —African focused natural resource Company. Offer TBC. Expected Mid July.

Harvey Nash Group — Provider of professional recruitment and offshore solutions moving to AIM from Main. No capital to be raised.  Mkt Cap c. £57.8m.

Greencoat Renewables  - Schedule 1. Targeting a portfolio of operating renewable electricity generation assets, initially investing in wind generation assets in Ireland.  Offer TBC. Due Mid July.

I3 Energy –Schedule 1 Update. Independent oil and gas Company with assets and operations in the UK.  Issue price of 55p with anticipated market cap of £14.3m, 25 July Admission.

Verditek— Sch 1 update. The Company's subsidiaries will be involved in advanced solar photovoltaic, filtration and absorption technologies specialising in providing environmental services. Issue price 10p.  Admission late June.

Main Market Premium Listing

Hipgnosis Songs Fund investment Company offering pure-play exposure to Songs and associated musical intellectual property rights. Prospectus yet to be published.

Impact Investment Trust —Exposure to a diversified portfolio of funds providing SMEs across developing economies with the growth capital they need to have a positive impact on the lives of the world's poorer populations. Raising up to $150m at $1.00.

Curzon Energy —Report on Proactive Investors of intended LSE float this year  with acquisition of  coal bed methane assets in Oregon. Looking to raise £3m plus.

Kuwait Energy — has not been able to complete its initial public offering as announced in its Intention To Float of 3 May 2017. However, in light of positive feedback from potential investors, the Company remains committed to obtaining a London listing and continues to explore its options.

Main Market Specialist Funds

Supermarket Income REIT – Up to £200m raise to acquire a diversified portfolio of supermarket real estate assets in the UK, providing long-term RPI-linked income. Due 21 July.

Lunch buffet

Horizon  Discovery Group (LON:HZD) 223.5p £206.8m

The Company focused on the application of gene editing technologies announced it has entered into an agreement to acquire Dharmacon from General Electric Company for a total consideration of $85m (£65m). Upon completion, conditional upon certain approvals, General Electric Company will receive $50m in cash and a subsidiary of General Electric Company will be issued with $35m in new Ordinary Shares in Horizon to be valued at the Placing Price of 205p. The Company also announced that it will raise £76.4m at the Placing Price of 205p. Dharmacon delivered revenues of $36.7m in the year ended 31 December 2016 and EBITDA of $5.4m.

Hotel Chocolat (LON:HOTC) 336p £379.14m

The premium British chocolatier and omni-channel retailer, provided a trading update for the 53 weeks ended 02 July 2017. Revs for FY17 was £105m, an increase of 12% compared to the prior year, slightly ahead of market expectations. Two new stores opened in HY17 bringing the total to 12 stores opening in FY17, which contributed to 5% of revs. Trading since FY17 continues to be in line with management's expectations. "Hotel Chocolat has had another good year, with encouraging growth. We are excited about the progress made with our new shop+cafe format stores and our seasonal ranges continue to perform well."

Tiziana Life Sciences (LON:TILS) 171.88p £167.72m

The clinical stage biotechnology Company developing targeted drugs for cancer and inflammatory diseases announced the enrolment of the first patient in its phase IIa clinical trial with milciclib, a novel inhibitor of cyclin-dependent kinases (CDKs), in patients with refractory hepatocellular carcinoma (HCC). Top line data from this trial is expected in Q4 2018.  "HCC is a real unmet medical need due to its growing incidence and lack of effective therapy.  It is the fifth most common cancer worldwide and the second most common cause of death from cancer worldwide."

DP Poland (LON:DPP) 45.25p £61.06m

The Company with the exclusive right to develop, operate and sub-franchise Domino's Pizza stores in Poland provided an update on store performance in H1 2017. Total system sales were up 50% to PLN27m compared to the same period last year. This is the 19th consecutive quarter of double digit system sales growth. 10 new stores opened to date in 2017, totalling 45 stores in 18 towns and cities to date in 2017. "We continued to see strong growth in system sales in the first half of 2017, thanks to robust double digit like-for-likes and 10 store openings, year to date. 8 additional towns and cities have been added to the Domino's map in Poland so far this year…”

PCF Group (LON:PCF) 23.75p £48.28m

The parent of the specialist bank, PCF Bank Limited, reported that the Bank received notification from its dual regulators, the PRA and the FCA, that the regulatory restrictions of the bank mobilisation period have been lifted and it can now commence deposit taking activities as a fully-operational bank. The Group is now adopting the trading style of PCF Bank. New business originations in FY17 Q3 were up 20% on the corresponding quarter last year, with the quality of the loan book further improved with the introduction of prime business trials. Given the Group's positive trading in FY17 Q3, the Board now expects the Group's performance for the year ending 30 Sept 2017 to be slightly ahead of its previous expectations for profitability and portfolio quality.

Amadale Capital (LON:ACP) 1.4p £3.10m

The investment Company focused on a natural resource project in Africa provided an update on exploration activities at it Mahenge Liandu Graphite Project in Tanzania. Stage One to focus on processing higher grade mineralisation before a later expansion to take advantage of the large size of the deposit for Stage Two. 2,500m Reverse Circulation (RC) drill programme underway. Drilling follows completion of road access and construction of 25 drill pads. Road access has exposed wide zones up to 110m of graphite mineralisation near surface. Identified and met with a number of potential offtake partners in China.

The People’s Operator (LON:TPOP) 3.12p £3.90m

The cause-based commercial mobile virtual network operator, announced the following Board changes. Michael Butler appointed as NED on 25 Jan 2017 and is offering himself for election as NED at the Company’s AGM. Mark Epstein, CEO, has informed the Board he will be stepping down with immediate effect. Mark will remain with the Company on part-time basis. Sam Tilloston, COO, has been appointed Acting CEO reporting to the Board. Christian Hernandez Gallardo is stepping down as NED at the AGM.

ReNeuron Group (LON:RENE) 1.75p £55.38m

The Company focused on the development of cell-based therapeutics announced that Dr Paul Harper, NED, of the Business will step down from the Board at the Company’s next AGM in September 2017. The Company intends to appoint a further non-executive to the Board and will make an announcement in this regard in due course. 

Tlou Energy (LON:TLOU) 8.12p £23.94m

The Company focused on delivering power in Botswana and southern Africa through the development of coal bed methane provided an operational report on its Project in Botswana. Contract for 250km seismic survey signed to commence in Q3 with aim to increase Gas Reserves and     Resources. Mining Licence application lodged. First power generated from CBM following the installation of a Gas Generator - providing reduced spend     on diesel and a proof of concept of 'first gas monetisation'. Board bolstered with appointment of Non-Executive Director Hugh Swire and post quarter end the appointment of Ms. Linah Mohohlo.

Venture Life Group (LON:VLG) 64.5p £23.58m

The international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population announced the signing of a new long term distribution agreement for its UltraDEX range across four new markets.  The Company has entered into a partnership with Karo Pharma AB (Sweden), a publicly listed Company for its UltraDEX range of products.  This long term distribution agreement covers Norway, Sweden, Denmark and Finland. "Karo Pharma AB becomes our latest international partner for the UltraDEX brand and we are delighted to partner with such a well- established public company in four new markets.  The extension of our patent portfolio into Europe also strengthens the brand's value and opportunity for further international partner opportunities."

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use